Patents by Inventor Floyd Taub

Floyd Taub has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240041802
    Abstract: The present disclosure provides methods, kits, and compositions comprising ?-alethine and one or more immune modulators and methods to determine when they are advantageous. Particular applications include the use of ?-alethine and one or more immune modulators in the treatment of cancer.
    Type: Application
    Filed: June 5, 2023
    Publication date: February 8, 2024
    Inventors: Floyd TAUB, Amanda Guth
  • Publication number: 20230332244
    Abstract: The present invention relates to methods for the rapid assessment of the efficacy of cancer therapies based on the detection of nucleic acid markers early after the onset of said therapies, as well as application of said methods in cancer therapy and clinical trial design. Novel clinical trial designs that allow approval of a drug as part of a plan requiring diagnostic testing while on drug and changing to standard of care within the same experimental arm are presented. They allow approval of a drug as part of a procedure when the drug alone would not be approved.
    Type: Application
    Filed: January 31, 2023
    Publication date: October 19, 2023
    Inventor: Floyd TAUB
  • Patent number: 11672771
    Abstract: The present disclosure provides methods, kits, and compositions comprising ?-alethine and one or more immune modulators and methods to determine when they are advantageous. Particular applications include the use of ?-alethine and one or more immune modulators in the treatment of cancer.
    Type: Grant
    Filed: November 3, 2017
    Date of Patent: June 13, 2023
    Assignees: AxImmune, Inc., Colorado State University Research Foundation
    Inventors: Floyd Taub, Amanda Guth
  • Publication number: 20200069616
    Abstract: The present disclosure provides methods, kits, and compositions comprising ?-alethine and one or more immune modulators and methods to determine when they are advantageous. Particular applications include the use of ?-alethine and one or more immune modulators in the treatment of cancer.
    Type: Application
    Filed: November 3, 2017
    Publication date: March 5, 2020
    Inventors: Floyd TAUB, Amanda GUTH
  • Patent number: 9655870
    Abstract: The present invention comprises homeopathic preparations of compounds, methods for using such preparations and delivery systems for the treatment of disease symptoms through the administration of these homeopathic compositions.
    Type: Grant
    Filed: February 2, 2007
    Date of Patent: May 23, 2017
    Assignee: FINDCURE.ORG
    Inventors: Floyd Taub, Neal Koller, Char Tara Albert
  • Publication number: 20080039523
    Abstract: An alternative method of delivery of homeopathic medicines by targeting delivery to the MALT's, especially of the intestinal tract and in high volumes.
    Type: Application
    Filed: February 10, 2005
    Publication date: February 14, 2008
    Inventors: Char Albert, Floyd Taub
  • Publication number: 20070212406
    Abstract: The present invention comprises homeopathic preparations of compounds, methods for using such preparations and delivery systems for the treatment of disease symptoms through the administration of these homeopathic compositions.
    Type: Application
    Filed: May 10, 2007
    Publication date: September 13, 2007
    Inventors: Floyd Taub, Neal Koller, Char Albert
  • Publication number: 20070141169
    Abstract: The present invention comprises homeopathic preparations of compounds, methods for using such preparations and delivery systems for the treatment of disease symptoms through the administration of these homeopathic compositions.
    Type: Application
    Filed: February 2, 2007
    Publication date: June 21, 2007
    Inventors: Floyd Taub, Neal Koller, Char Albert
  • Publication number: 20040019107
    Abstract: The present invention comprises homeopathic preparations of compounds, methods for using such preparations and delivery systems for the treatment of disease symptoms through the administration of these homeopathic compositions.
    Type: Application
    Filed: July 29, 2002
    Publication date: January 29, 2004
    Inventors: Floyd Taub, Neal Koller, Char Tara Albert
  • Patent number: 6498150
    Abstract: The present invention relates to peptide-like compounds, eg aminocarboxylic acid amide derivatives, and to methods of using same to stimulate cells of the immune system, bone marrow and other organs. The present compounds can be used to enhance vaccination, increase synthesis of and enhance function of blood cell components and enhance anti-neoplastic effects of various agents. The compounds of the invention can be used to produce a variety of further pharmacologic effects.
    Type: Grant
    Filed: October 7, 1999
    Date of Patent: December 24, 2002
    Assignee: Dovetail Technologies, Inc.
    Inventors: Floyd Taub, Thomas J. Perun, Christopher K. Murray, Randall J. Daughenbaugh, Daniel Lednicer
  • Publication number: 20020035118
    Abstract: The present invention relates to peptide-like compounds, eg aminocarboxylic acid amide derivatives, and to methods of using same to stimulate cells of the immune system, bone marrow and other organs. The present compounds can be used to enhance vaccination, increase synthesis of and enhance function of blood cell components and enhance anti-neoplastic effects of various agents. The compounds of the invention can be used to produce a variety of further pharmacologic effects.
    Type: Application
    Filed: October 7, 1999
    Publication date: March 21, 2002
    Inventors: FLOYD TAUB, THOMAS J. PERUN, CHRISTOPHER K. MURRAY, RANDALL J. DAUGHENBAUGH, DANIEL LEDNICER
  • Patent number: 6007819
    Abstract: The present invention relates to peptide-like compounds, eg aminocarboxylic acid amide derivatives, and to methods of using same to stimulate cells of the immune system, bone marrow and other organs. The present compounds can be used to enhance vaccination, increase synthesis of and enhance function of blood cell components and enhance anti-neoplastic effects of various agents. The compounds of the invention can be used to produce a variety of further pharmacologic effects.
    Type: Grant
    Filed: October 17, 1996
    Date of Patent: December 28, 1999
    Assignee: Dovetail Technologies, Inc.
    Inventors: Floyd Taub, Thomas J. Perun, Christopher K. Murray, Randall J. Daughenbaugh, Daniel Lednicer
  • Patent number: 5068909
    Abstract: An apparatus and method for removing background noise and high frequency noise from an image by comparing each pixel in the image with neighboring pixels defining a variably shaped and sized kernel. The size and shape of the kernel are optimized for the particular characteristics of the data to be analyzed.
    Type: Grant
    Filed: May 18, 1989
    Date of Patent: November 26, 1991
    Assignee: Applied Imaging Corporation
    Inventors: Hal Rutherford, Floyd Taub
  • Patent number: 4873187
    Abstract: A cationic detergent having a positively charged group and a hydrophobic group is used to conjugate an enzymatically active enzyme molecule with a single-stranded nucleic acid molecule. The conjugate may be used to detect the presence of nucleic acid molecules having a nucleotide sequence which is complementary to that of the single-stranded molecule of the conjugate.
    Type: Grant
    Filed: March 13, 1986
    Date of Patent: October 10, 1989
    Assignee: Digene Diagnostics, Incorporated
    Inventor: Floyd Taub
  • Patent number: 4820630
    Abstract: Lesions in genetic sequences, for example, the sickle cell anemia mutation in the beta globin gene, are detected by means of interactive labels in a nucleic acid hybridization assay. A signal is generated only if the labels are in physical proximity which is made dependent on whether a predetermined normal or abnormal sequence is present by exposure to appropriate conditions such as restriction enzyme digestion or stringent hybridization.
    Type: Grant
    Filed: November 23, 1984
    Date of Patent: April 11, 1989
    Assignee: Digene Diagnostics, Incorporated
    Inventor: Floyd Taub